This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mabry, R.
Right arrow Articles by Iverson, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mabry, R.
Right arrow Articles by Iverson, B. L.

 Previous Article  |  Next Article 

Infection and Immunity, December 2005, p. 8362-8368, Vol. 73, No. 12
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.12.8362-8368.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Passive Protection against Anthrax by Using a High-Affinity Antitoxin Antibody Fragment Lacking an Fc Region

Robert Mabry,1,2 Mridula Rani,2 Robert Geiger,3 Gene B. Hubbard,3 Ricardo Carrion Jr,4 Kathleen Brasky,3 Jean L. Patterson,4 George Georgiou,2,5* and B. L. Iverson1,2*

Department of Chemistry and Biochemistry, University of Texas at Austin, Austin, Texas,1 Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas,2 Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas,3 Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas,4 Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas5

Received 13 July 2005/ Returned for modification 16 August 2005/ Accepted 4 September 2005

Passive immunization has been successfully employed for protection against bacterial and viral infections for over 100 years. Immunoglobulin Fc regions play a critical role in the clearance of bacterial pathogens by mediating antibody-dependent and complement-dependent cytotoxicity. Here we show that antibody fragments engineered to recognize the protective antigen component of the B. anthracis exotoxin with high affinity and conjugated to polyethylene glycol (PEG) for prolonged circulation half-life confer significant protection against inhalation anthrax despite their lack of Fc regions. The speed and lower manufacturing cost of bacterially expressed PEGylated antibody fragments could provide decisive advantages for anthrax prophylaxis. Importantly, our results suggest that PEGylated antibody fragments may represent a unique approach for mounting a rapid therapeutic response to emerging pathogen infections.


* Corresponding author. Mailing address for George Georgiou: Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, 1 University Station, Austin, TX 78712. Phone:(512) 471-6975. Fax: (512) 471-7963. E-mail: gg{at}che.utexas.edu. Mailing address for B. L. Iverson: Department of Chemistry and Biochemistry, University of Texas at Austin, 1 University Station, Austin, TX 78712. Phone: (512) 471-5053. Fax: (512) 471-8615. E-mail: biverson{at}mail.utexas.edu.

Editor: J. D. Clements


Infection and Immunity, December 2005, p. 8362-8368, Vol. 73, No. 12
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.12.8362-8368.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Baer, M., Sawa, T., Flynn, P., Luehrsen, K., Martinez, D., Wiener-Kronish, J. P., Yarranton, G., Bebbington, C. (2009). An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity. Infect. Immun. 77: 1083-1090 [Abstract] [Full Text]  
  • Tang, S., Moayeri, M., Chen, Z., Harma, H., Zhao, J., Hu, H., Purcell, R. H., Leppla, S. H., Hewlett, I. K. (2009). Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles. CVI 16: 408-413 [Abstract] [Full Text]  
  • Harvill, E. T., Osorio, M., Loving, C. L., Lee, G. M., Kelly, V. K., Merkel, T. J. (2008). Anamnestic Protective Immunity to Bacillus anthracis Is Antibody Mediated but Independent of Complement and Fc Receptors. Infect. Immun. 76: 2177-2182 [Abstract] [Full Text]  
  • Staats, H. F., Alam, S. M., Scearce, R. M., Kirwan, S. M., Zhang, J. X., Gwinn, W. M., Haynes, B. F. (2007). In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity. Infect. Immun. 75: 5443-5452 [Abstract] [Full Text]  
  • Jeong, K. J., Seo, M. J., Iverson, B. L., Georgiou, G. (2007). APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering. Proc. Natl. Acad. Sci. USA 104: 8247-8252 [Abstract] [Full Text]  
  • Sherer, K., Li, Y., Cui, X., Eichacker, P. Q. (2007). Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy. Am. J. Respir. Crit. Care Med. 175: 211-221 [Abstract] [Full Text]  
  • Mabry, R., Brasky, K., Geiger, R., Carrion, R. Jr., Hubbard, G. B., Leppla, S., Patterson, J. L., Georgiou, G., Iverson, B. L. (2006). Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered Immunoassays. CVI 13: 671-677 [Abstract] [Full Text]  
  • McGuinness, C. R., Mantis, N. J. (2006). Characterization of a Novel High-Affinity Monoclonal Immunoglobulin G Antibody against the Ricin B Subunit.. Infect. Immun. 74: 3463-3470 [Abstract] [Full Text]  
  • Keim, P., Mock, M., Young, J., Koehler, T. M. (2006). The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05".. J. Bacteriol. 188: 3433-3441 [Full Text]